Both in Surgical Instruments
Pulse Biosciences, Inc Common Stock (DE) vs Haemonetics
Over the past year PLSE returned +210.9% and HAE returned +139.3%; their daily moves had a correlation of -0.04.
PLSE +210.9% HAE +139.3%Growth of $1, one year, split-adjusted
| Metric | PLSE | HAE |
|---|---|---|
| Price | $52.20 | $120.28 |
| Market cap | $3.72B | $5.47B |
| Today | −1.32% | +0.12% |
| 1 month | +3.4% | +14.9% |
| 6 months | +179.9% | +116.3% |
| Year to date | +280.2% | +50.1% |
| 1 year | +208.3% | +140.5% |
| Revenue growth (YoY) | — | +5.6% |
| Gross margin | 37.1% | 59.8% |
| Net margin | −5681.3% | 9.7% |
| P/E (TTM) | — | 56.8× |
| Price / sales | 3,141.8× | 4.0× |
| Net cash | $101.6M | -$950.8M |
| Dividend yield | — | — |
| Volatility (60d) | 61.3% | 48.5% |
| Short % of float | 16.4% | 7.7% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).